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Abstract:  The aim of the present study was to investigate effects of pomegranate peel (PP) extract on different 
human cancer cell lines. MTT was performed to estimate cytotoxic effects of PP extract against HTB140, 
HTB177, MCF7, HCT116 human cancer cell lines and MRC-5 normal fibroblasts. Clonogenic assay was used 
to reveal cell survival after the treatment with PP extract. Cell cycle analysis was done using flow cytometry. 
Wound healing assay was applied to estimate inhibitory effects of PP extract on migration of cancer cells. The 
results showed that PP extract expressed selective cytotoxicity for cancer cells compared to normal cell line. 
Analyzed cancer cell lines displayed individual variations in sensitivity to PP extract reflected through changes 
in clonogenic survival, cell cycle distribution and migration, which may be due to the specific nature of each 
tested cell line. In conclusion, PP extract exhibits good inhibitory effects on tested cancer cell lines.  
 
Keywords: Punica granatum L.; peel extract; phenolic compounds; cytotoxicity; cancer cells. © 2020 ACG 
Publications. All rights reserved. 
 
1. Introduction 
Pomegranate (Punica granatum L.), is known as medicinal plant since ancient times, and is 
also considered as a mystical plant [1]. It is fruit-bearing shrub which originates from Middle East 
and India [2]. Historically, pomegranate has well documented appreciation in many cultures as a 
symbol of longevity and health [3]. All parts of the tree, including peel, have particular application 
especially in traditional medicinal systems such as Chinese, Ayurvedic and Unani [4]. For example, 
in ethnomedicine it is used as a remedy for various pathological conditions such as diabetes, 
dysentery, malaria, dental plaque and intestinal infections [5, 6]. Some of the modern uses of 
pomegranate include treatment of cardiovascular conditions [7], and cancer [8], in addition to the use 
in oral hygiene [9] and cosmetics [10]. Over the last few decades, accumulating scientific data reveal 
that antioxidant, anti-inflammatory and anti-cancer activity of pomegranate can be largely attributed 
to its high content of polyphenols. Lansky and Newman [11] concluded that pomegranate extracts 
could find clinical applications in many diseases where chronic inflammation is believed to play an 
essential etiology, such as cancer. Both, edible parts as well as nonedible peel are rich sources of 
bioactive ingredients. According to Trolox equivalent antioxidant capacity assay, antioxidant activity 
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of pomegranate juice is three times higher compared with green tea and red wine [12]. Pomegranate 
peel (PP) is significant natural source of phenolics such as ellagitannins, proanthocyanidins, and 
flavonoids. Among typical compounds, ellagic and gallic acids, punicalagin and punicalin are 
reported [13, 14, 15].  However, it has been shown that besides acting as antioxidants, polyphenols 
also show pro-oxidant activity, especially at higher concentrations [16, 17, 18]. For example, the pro-
oxidant effects of curcumin and carvacrol have been demonstrated in both cancer and normal cells 
[17, 18].  
It has been estimated that by 2030, the number of new cancer cases will reach 26 million and 
there will be 17 million deaths caused by cancer per year [19]. Since cancer incidence rates are 
higher in elderly population, this can be attributed to demographic changes, i.e. growth and aging of 
population [20]. Although new cutting-edge therapies such as gene therapy and nanomedicine are 
coming to the scene, surgery, chemotherapy and radiotherapy remain the basis of cancer treatments 
available today. Modern management of cancer also practices multimodal therapy approach which 
includes the use of different combinations of anticancer agents [21, 22]. However, treatment outcome 
remains unsatisfactory due to the developed chemo-resistance and severe side effects on healthy 
tissue [23]. Slow growth is one of the features of many types of cancers that can be exploited in 
treatment strategy. For some tumors it can take decades before the onset of invasive disease, thus 
leaving opportunity for preventive interventions [20]. Hence, the future cancer treatments should be 
oriented to prevention as well as to discovery of the new chemical compounds with selective toxicity 
toward cancer cells. Ideally, the new drugs would also have the potential to reduce the harmful 
effects when combined with other treatment modalities, i.e. radiation [24]. Recently, the interest has 
been raised for pharmacologically safe, naturally derived compounds, such as plant polyphenols due 
to their potent antioxidant properties. Although still limited, ongoing research data suggest that 
phytochemicals can also serve as effective chemo- or radio-sensitizers in multimodal cancer therapy 
[25]. 
The aim of this works was to test cytotoxic properties of PP extract on different human 
cancer cell lines. Cytotoxic effects of the compound affecting cell viability and proliferation, as well 
as cell cycle distribution and migration were investigated. In order to estimate the effects of the 
extract on healthy tissue, PP extract was also tested on normal human lung fibroblast cells. Obtained 
data would serve as a starting point for the experiments including combined treatments of PP extract 
with various cancer therapeutic tools such as low and high ionizing radiation. 
 
2. Materials and Methods 
2.1. Standards and Reagents 
 
Standard punicalin was purchased from Phytolab (Vestenbergsgreuth, Germany), 
punicalagin (α+β) from Sigma-Aldrich (Steinheim, Germany), while ellagic and gallic acids were 
obtained from Extrasynthese (Cedex, France). Reagents which were used for experimental 
procedures were analytical grade. Folin–Ciocalteu phenol reagent was acquired from Sigma-Aldrich, 
(Steinheim, Germany), while formic and orthophosphoric acid, sodium carbonate and methanol were 
purchased from Sigma–Aldrich (Chemie GmbH, Munich, Germany). Acetonitrile was HPLC grade 
(Merck, Germany). 
 
2.2. Plant Material 
 
Ripe fruits of wild growing pomegranate were harvested during November 2016 in village 
Do (Bosnia and Herzegovina). Manually separated peel was air-dried 4-6 days at room temperature 
and grounded prior extraction in a laboratory mill. The voucher specimen (No. N42/15) was 
deposited in the Institute for Medicinal Plants Research “Dr Josif Pancic”, Belgrade.  
    
2.3. Extraction Procedure 
 
Extraction procedure was according to our previously published data [13]. Briefly, powdered 
pomegranate peel (50 g) was extracted with 50% ethanol in ultrasonic bath during 40 min at 60ºC. 
Cytotoxic activity of pomegranate peel extract 
 
328 
Obtained extract was filtered and evaporated to dryness by rotary evaporator (Büchi R-210, Flawil, 
Switzerland). 
 
2.4. Total Phenolics Content 
 
Total phenolic content was determined spectrophotometrically using Folin-Ciocalteu (FC) 
according to the method of Waterman and Mole [26]. Briefly, 200 µL of properly diluted extract 
were mixed with 1 mL of diluted FC reagent (1:10). 800 microliters of sodium carbonate (75 g/L) 
were added after 4 min and after 2 h of incubation at room temperature absorbance was measured at 
765 nm. For the preparation of calibration curve, gallic acid (0–100 mg/L) was used. The results 
were expressed as milligrams of gallic acid equivalents per gram of dry weight (mg GAE/g DW). 
Experiments were performed in triplicate. The results were obtained with Spectrophotometer Hewlett 
Packard 8453 (Waldbronn, Germany). 
 
2.5. Total Tannins Content  
 
Total tannins content was analyzed according to European Pharmacopoeia (Ph Eur 7.0) [27]. 
Briefly, properly diluted extract, with and without previous treatment with hide powder, was mixed 
with phosphomolybdotungstic reagent in alkaline medium. The absorbance was measured at λmax 
760 nm (UV-VIS Spectrophotometer HP 8453, Agilent Technologies, USA). The content of tannins 
is expressed as pyrogallol %, w/w and was calculated from the difference in absorbance of total 




where m1 represents mass of the sample to be examined, in grams and m2 and A3, mass in grams 
and absorbance of pyrogallol, respectively. Experiments were repeated three times. 
 
2.6. Total Flavonoids Content 
 
Total flavonoid content was analyzed spectrophotometrically according to Zhishen, et al. 
[28]. Briefly, 100 microliters of extract were mixed with 4 mL of distilled water and 0.3 mL 5% 
sodium nitrite was added. 0.3 mL of 10% aluminum chloride was added after 5 min. After 6 min, 2 
mL of 1 M sodium hydroxide was added to the mixture and the mixture was diluted by the addition 
of 3.3 ml of distilled water. The absorbance was measured at 510 nm. Catechin was used as standard 
for the calibration curve. Total flavonoids content was expressed as mg catechin equivalents per 
gram of dry weight (mg/g DW). Experiments were repeated three times. Results were obtained with 
Spectrophotometer Hewlett Packard 8453 (Waldbronn, Germany). 
 
2.7. High Performance Liquid Chromatography 
 
HPLC analyses were carried out on Agilent 1200 RR HPLC (Waldbronn, Germany), 
equipped with DAD detector, analytical column Zorbax SB-C18 (5 µm; 150 mm × 4.6 mm i.d; 
column temperature 25ºC.). The injection volume was 5 μL. The mobile phase A was solution of 
orthophosphoric acid in water (1% v/v) and mobile phase B was acetonitrile, flow rate was 1 
mL/min. Gradient elution was employed according to the following scheme: 98-90% A (0-5 min); 
90% A (5-15 min); 90-85% A (15-20 min); 85-70% A (20-25 min); 70-40% A (25-30 min); 40-0% 
A (30-34 min). Detection was done at 260 and 320 nm. For the quantification, calibration curves of 
standards gallic and ellagic acid, punicalagin (α+β) and punicalin were used. The results were 
express as milligrams per gram of dry weight. Experiments were repeated three times. 
 
2.8. Cell Culture 
 
The following human cancer cell lines, HTB140 melanoma, HTB177 large cell lung 
carcinoma, MCF7 breast carcinoma, HCT116 colon carcinoma as well as MRC-5 normal lung 
fibroblasts, used in this study, were purchased from ATCC (Manassas, VA, USA). Cells were grown 
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as monolayers in RPMI 1640 medium (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) 
supplemented with 10% fetal bovine serum (Sigma-Aldrich Chemie GmbH) and a mixture 
containing 5000U penicillin and 5 mg/mL streptomycin in 0.9% sodium chloride (Sigma-Aldrich 
Chemie GmbH). The cells were maintained at 37°C, in a humidified atmosphere of 5% CO2 
(Heraeus, Hanau, Germany). 
 
2.9. Cytotoxicity Testing (MTT Assay)  
 
For determination of cell viability loss after administration of PP extract, the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium reduction assay was performed 
according to manufacturer’s instructions (Sigma-Aldrich, Germany). Human cancer cell lines, as 
well as normal fibroblasts, were seeded at suitable number in microtiter plates with 96 wells 
(Sarstedt AG & Co., Nümbrecht, Germany) and incubated overnight when different concentrations 
of PP extract were added to the wells. The 100 mg/mL stock solution of the plant extract was 
previously prepared in culture medium containing 5% DMSO. Final concentrations of extract were 
obtained by diluting stock solution in RPMI medium. Therefore, final concentration of DMSO in 
samples did not exceed 0.1%. Cells were treated with seven different concentrations of extract: 
15.63, 31.25, 62.5, 125, 250, 500 and 1000 μg/mL for 24 and 48 h. After that, cells were incubated 
with MTT (0.5mg/mL) for 4 hours under standard culture conditions. For that time, in metabolically 
active viable cells, yellow MTT was reduced to purple formazan by mitochondrial dehydrogenase. 
After dissolving formazan crystals in DMSO (SERVA Electrophoresis GmbH, Heidelberg, 
Germany), absorbance was measured in an ELISA plate reader (Victor2 1420 Multilabel counter, 
Wallac, Turku, Finland), at a wavelength of 550 nm. Experiments were performed in triplicates and 
repeated in three independent series. IC50 was calculated by non-linear regression analysis of the 
data with the ED50plus v1.0 Software (http://www.softlookup.com/download.asp?ID=2972). Using 
IC50 values obtained at 24 h and 48 h, selectivity index (SI) was determined according to the 
formula: 
 
SI= IC50(fibroblast cell line)/IC50(tumor cell line) 
 
For the values SI>2 it is considered that PP extract is highly selective for malignant cells compared 
to normal cell line. 
 
2.10. Clonogenic Assay 
 
To estimate cell survival after the treatment with PP extract, clonogenic assay was 
performed. Briefly, cells were harvested by trypsinization (0.25% trypsin, Serva Feinbiochemica, 
Heidelberg, Germany) and seeded at a suitable number into the 6-well plates (Sarstedt AG & Co., 
Nümbrecht, Germany). Exponentially growing cells were treated for 24 h with PP extract. Two 
concentrations (16 and 32 μg/mL) were chosen for the treatment since it has been shown that for all 
cell lines used in this experiment these concentrations were lower than the IC50 values estimated by 
MTT assay. After the incubation at standard conditions (37 °C, 5% CO2) for 7 days, cells were fixed 
with methanol (Zorka Pharma, Hemija, d.o.o., Sabac, Serbia) and stained with 10% Giemsa solution 
(Alkaloid A.D., Skopje, FYROM). More than 50 cells per colony were scored as a surviving cell. 
Survival was calculated by comparing the number of colonies in samples treated with PP extract with 
the number of colonies in the untreated control. Plating efficiency (PE) and surviving fraction of the 
cells after the treatment were calculated using subsequent formulas: 
 
PE = no. of colonies formed/ no. of cells seeded x 100% 
SF = no. of colonies formed after treatment/ no. of cells seeded x PE 
 
2.11. Cell Cycle Analysis 
 
In order to estimate changes in cell cycle, cells were treated with 16 μg/mL PP extract and 
analyzed 24 and 48 h later. Approximately 1 x 106 cells were fixed in cold 70% ethanol and 
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incubated with 1 mg/mL ribonuclease A (Rnase A, Sigma-Aldrich Chemie GmbH), for 15 min at 37° 
C. After incubation, the cells were stained with 50 µg/mL of propidium iodide (PI, Sigma-Aldrich 
Chemie GmbH), and 10 000 cells per sample were analyzed on CyFlow® flow cytometer (Partec 
GmbH, Münster, Germany). The results were analyzed using FloMax® software. 
 
2.12. Analysis of Cell Migration  
 
Cells were seeded in 12-well plates in triplicate and cultured to form a confluent monolayer. 
A scratch was made using 200 μL pipette tip and detached cells were removed by washing with PBS. 
As for the cell cycle analysis, the same non-toxic concentration of extract (16 μg/mL) was used for 
the treatment. Images were captured with inverted microscope (Carl Zeiss, Jena, Germany) at the 
moment of treatment (0 h) and 24 h later. Photographs were analyzed using MRI Wound Healing 
Tool plugin in ImageJ software. 
 
2.13. Statistical Analysis 
 
All biological experiments were done at least in triplicate and were repeated tree times. 
Graphs were plotted using commercial SPSS version 20.0 or Origin8 software. Depending on data 
distribution statistical evaluation was performed by Student’s t-test or one-way ANOVA with post 
hoc analysis of dose differences carried out by Tukey's test. Results were considered statistically 
significant for p < 0.05. The results are expressed as mean values with standard error of the mean 
(SEM). 
 
3.  Results and Discussion  
 
3.1. Chemical Analysis 
 
HPLC chromatogram of ethanol extract of pomegranate peel is presented in Figure 1. Chemical 
composition of the PP extract was analyzed spectrophotometrically for the determination of total 
phenols, tannins and flavonoids content (Table 1), as well as by HPLC method for the quantification 
of individual compounds (punicalin, punicalagin, ellagic and gallic acids) which is presented in 




Figure 1. HPLC chromatogram of ethanol extract of pomegranate peel detected at 260 nm 
         1: Gallic acid; 2: Punicalin; 3a: α – Punicalagin; 3b:β– Punicalagin; 4: Ellagic acid 
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Table 1. Total phenolics, total flavonoids and total tannins content in dry pomegranate peel extract 
Compounds Content 
Total phenolics  
Total flavonoids 
Total tannins 
367.33 ± 3.99 mg GAE/g DW 
    6.06 ± 0.37 mg catechin/g DW 
  27.52 ± 1.21 % 
 
Table 2. HPLC quantification of dominant compounds in dry pomegranate peel extract. 





  50.92 ± 0.22 
182.41 ± 0.86 
    6.11 ± 0.02 
  22.54 ± 0.05 
 
3.2. Biological Response to PP Extract 
 
In this experimental setup, the effects of PP extract were analyzed on four human cancer cell 
lines derived from different tumors. Moreover, cytotoxicity was also tested on normal human 
fibroblasts in order to estimatethe effects of the extract on normal, healthy tissue. From a wide range 
of concentrations examined with MTT, 16 and 32 μg/mL PP extract were chosen for clonogenic 
assay so as to determine reproductive death of the cells after the treatment. Since under chosen 
experimental conditions 32 μg/mL PP extract in clonogenic assay for all cell lines showed strong 
killing effect, for cell cycle analysis and migration assay only the lower concentration of 16 μg/mL 
was used. In all experiments, incubation period with PP extract lasted for 24 h or 48 h. After that 
period, biological assays were performed as indicated. 
 
3.2.1. Cytotoxic Effects of PP Extract  
 
Cytotoxicity profiles of PP extract in HTB140, HTB177, MCF7, HCT116 and MRC-5 cells 
are given in Figure 2. There was a statistically significant difference between groups as determined 
by one-way ANOVA. A Tukey post hoc test revealed dose-dependent increase of cytotoxicity 
induced by PP in all tested cell lines at both 24 h and 48 h time points. Concentrations of PP extracts 
higher than 62.5 µg/mL provoked a statistically significant increase in cytotoxicity compared to 
concentration of 16 µg/mL.  
Corresponding half maximal inhibitory concentration values (IC50) and degree of selectivity 
are presented in Table 3. According to the data obtained with MTT, for MRC-5 fibroblasts, rather 
high concentrations of extract were required to achieve 50% drop in cell viability compared to cancer 
among tested cancer cell lines, HTB140 melanoma cells responded to extract quite similar to normal 
fibroblasts, with IC50 values rising from ~ 118 µg/mL at 24 h to ~ 179 µg/mL at 48 h. Other cancer 
cell lines were more sensitive to PP extract. The IC50 value for HTB177 cells measured at 24 h was 
~ 55 µg/mL, whilst, probably due to the loss of extract potency, detected IC50 values were almost 
twofold higher (~120 µg/mL) at 48 h. For HCT116 and MCF7 cells, an increase of extract toxicity 
was observed with prolonged incubation. Accordingly, for HCT116 cells, IC50 dropped from ~ 75 at 
24 h to ~ 40 µg/mL at 48 h, though for MCF7 a milder decline of IC50 was detected (~ 39 and ~ 31 
µg/mL, respectively). 
Degree of selectivity (selectivity index, SI) was expressed through comparison of normal and 
cancer cell response to PP extract and is given in Table 3. Measured at 24 h, SI values for all cell 
lines were higher than 2, indicating high specificity of the extract towards cancer cell lines. At 48 h, 
SI was still high for MCF7 and HCT116 cells (~ 6 and ~5, respectively). 
 




Figure 2. Growth inhibition of HTB140 cells  
(a), HTB177 cells (b), MCF7 cells (c), HCT116 cells (d) and MRC-5 cells (E) after 24 h and 48 h treatment 
with 15.63, 31.25, 62.5, 125, 250, 500 and 1000 μg/mL PP extract measured by MTT assay. Enlarged scale is 
presented next to the corresponding figure. Results are expressed as mean ± SEM (standard error of the 
mean). 
Keta et.al., Rec. Nat. Prod. (2020) 14:5 326-339 
 
333 
Table 3. Cytotoxic activity of pomegranate peel extract against cancer cell lines  
Cell line IC50 values ± SEM SI (selectivity index) 






117.57 ± 1.99 
  55.15 ± 1.09 
  38.92 ± 2.34 
  74.85 ± 2.99 
166.65 ± 0.33 
178.57 ± 2.35 
119.75 ± 0.64 
  31.29 ± 1.63 
  40.15 ± 1.25 
189.15 ± 0.05 
1.42 ± 0.02 
3.02 ± 0.06 
4.28 ± 0.26 
2.23 ± 0.09 
1 
1.06 ± 0.01 
1.6 ± 0.01 
6.05 ± 0.32 
4.71 ± 0.15 
1 
* Selectivity index (SI) is estimated as the ratio between IC50 values of normal and cancer cells treated with PP 
extract, at corresponding time points (24 and 48 h). Data were calculated by non-linear regression analysis using 
data obtained by MTT assay from cell samples treated with PP extract for 24 and 48 h 
            
 
3.2.2. Effects of PP Extract on Cell Survival 
 
Considering the cytotoxicity data obtained by MTT assay (Figure 2), we have selected 
concentrations of 16 µg/mL and 32 µg/mL as optimal for the analysis of cell survival assuming that 
PP extract at higher concentrations would cause overkill. As presented in Figure 3, clonogenic assay 
showed high inhibitory effects of PP extract. Cells were treated for 24 h with the extract and colonies 
were counted 7 days later. Survival data showed that only HTB140 and HTB177 cells survived the 
lower concentration of 16 µg/mL PP extract. With SF (16 µg/mL) of 0.74, HTB177 cells were more 
resistant to the extract compared to HTB140 cells, having SF(16 µg/mL) of 0.47. For both cell lines, 
decrease in cell survival was statistically significant (P<0.001) as compared to the control. In 
samples treated with 32 µg/mL of extract practically no colonies were counted. 
 
 
Figure 3. Survival of HTB140, HTB177, MCF7 and HCT116 cells after 24 h treatment with 16 and 
32 μg/mL PP extract (PP) estimated by clonogenic assay 
Results are presented as mean ± SEM. Statistical significance compared to the control, * 0.01 <p <0.05; ** 
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3.2.3. Effects of PP Extract on Cell Cycle  
 
Cell cycle changes were monitored 24 and 48 h after treatment with 16 µg/mL of PP extract 
(Figure 4). We have tested this concentration because the PP extract at 32 µg/mL strongly inhibited 
cell survival as shown by clonogenic assay (Figure 3). As a response to the treatment, HTB140 cells 
expressed arrest in G2/M cell cycle phase at 48 h time period (p<0.01). Moreover, at this time, the 
loss of HTB140 cells in S phase was also observed (p<0.05). Other cancer cell lines showed smaller 
changes in cell cycle distribution after the treatment. In HTB177 and MCF7 cells, a slight increase of 
S phase compared to control samples was observed at 48 h (p<0.05), whilst HCT 116 showed minor 
G1 block at 48 h (p<0.05). 
 
Figure 4. Cell cycle analysis of HTB140, HTB177, MCF7 and HCT116 cells after treatment with  
16 μg/mL PP extract (PP). Analyses were performed at 24 h and 48 h. 
Results are expressed as mean ± SEM. Statistical significance compared to the control, * 0.01 <p <0.05; ** 
0.001 <p <0.01; *** p <0.001. 
 
3.2.4. Effects of PP Extract on Cancer Cell Migration  
 
Ability of cancer cells to migrate after wounding cell monolayer treated with 16 µg/mL PP 
extract is presented in Figure 5. In general, similar migratory ability was detected for HTB140 and 
HCT116 cells with no statistically significant changes detected between treated and untreated cells. 
PP extract had higher inhibitory effect on migration of MCF7 and HTB177 cells. For MCF7 cells, 
wound surface measured after the treatment was higher (~72%) compared to control (44%). For 
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HTB177 statistically significant changes in cell migration was observed with ~72% wound surface 
compared to control cells (~ 20%). 
 
 
Figure 5. Migration of HTB140, HTB177, MCF7 and HCT116 cells after 24 h treatment with 16 
μg/mL PP extract (PP) estimated by wound healing assay. Photographs were taken at the time of 
extract administration (0 h) and 24 h later 
Results are expressed as mean ± SEM. Statistical significance of wound surface in untreated control (24 h vs. 0 
h) and in cells treated with 16 μg/mL PP (24 h vs. 0 h), * 0.01 <p <0.05; ** 0.001 <p <0.01; *** p <0.001.  
#Statistical significance of wound surface at 24 h (control vs. 16 μg/mL PP), # 0.01 <p <0.05; ## 0.001 <p 
<0.01; ### p <0.001 
 
3.3. Previous Reports on Biological Activities of PP: Correlation to its Inhibitory Effects on Cancer 
Cells 
 
Pomegranate fruit is a rich source of biologically active compounds particularly phenolic 
compounds with ellagitannins, anthocyanins, proanthocyanidins, flavonoids as characteristic groups. 
Usually the inner part of the pomegranate fruit (arils with the seeds) is used in fresh condition or as a 
juice. The residue after juice production (hard pericarp together with yellow-white soft mesocarp) 
represents almost 50% of whole fruit and it is routinely discarded as a waste [29]. Recently, a 
number of studies have been conducted showing that pomegranate peel is particularly rich in 
ellagitannis (mainly punicalin and punicalagin) and ellagic acid which are considered as potent 
biologically active phenolic compounds resulting in different beneficial effects on human health [11, 
30, 31]. PP extract used in the present study was abundant in phenolic compounds. Compared with 
other authors’ reports total phenolics content in our PP extract was higher. Hasnaoui et al. [32] 
reported lower amounts of total phenolics (205-276 mg GAE/g) similar to the results of Masci et al. 
[33] where in the pomegranate peel 255 mg of total phenolics were determined. The amount of total 
flavonoids in our PP extract was similar to the results obtained by El-Said et al. [34] ranging from 
6.32 to 7.98 mg RE/g. Differences in the content of total phenolics, tannins and flavonoids could be 
explained by different extraction conditions (type of the solvents, extraction method, temperature, 
duration of the extraction). Among individual compounds, ellagitannin punicalin was a dominant 
compound in our extract followed by ellagitannin punicalagin. Also, high amount of ellagic acid was 
present in PP extract. Punicalagin and ellagic acid were among major compounds in pomegranate 
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peel analyzed by Masci et al. [33], where approximately twice as less amounts have been reported 
(28.45 mg/g and 11.85 mg/g, respectively).  
Previous data obtained by DPPH test showed good radical scavenging capacity of PP extract 
[35]. Moreover, pomegranate polyphenols revealed mixed pro- and ant oxidative effects in cultured 
cells [17, 18, 36]. With the aim of investigating the effects of PP extract in human cancer, four 
cancer cell lines of different tumor origin were used in this study. We have specially selected those 
cancer cells since they represent aggressive cancer models and display a high metastatic potential. 
For example, HCT116 colon cancer and HTB177 lung cancer cells are frequently used for 
investigation of molecular mechanisms of metastasis as well as anti-metastatic therapeutic strategies 
[37, 38]. HTB140 cell line represents aggressive form of melanoma which in general accounts for 
65% of all deaths from skin cancer [39]. It has also been shown that MCF-7 breast cancer cells are 
able to metastasize to lungs, liver and spleen when injected into athymic nude mice [40].  
According to the literature data, several studies investigated the effects of different fractions 
extracted from pomegranate on various cancer cell lines. Research conducted by Seeram et al. [41] 
evaluated antiproliferative activity of punicalagin, ellagic acid, total pomegranate tannin extract and 
pomegranate juice extract against several human oral, colon (including HCT116 cells) and prostate 
tumor cells. According to the results of this study, all pomegranate ingredients decreased cell 
viability in a dose-dependent manner in all cell lines tested. However, anti-proliferative activity of 
pomegranate juice is found to be superior compared to other tested purified polyphenols, which 
indicates that anti-carcinogenic properties can be attributed to synergistic effect of single active 
ingredients of pomegranate [41]. In the present study, we have shown that PP extract also has 
inhibitory effect on HCT116 colon cancer cell line which is probably due to combined activity of 
individual polyphenolic compounds of pomegranate peel. In the study of Dana et al. [42], black PP 
extract displayed anti-proliferative effects on B16F10 melanoma cells. Although active compound in 
black PP extract, which is responsible for the inhibitory effects on melanoma cell proliferation is not 
revealed, the authors proposed antioxidant effects and polyphenol content as responsible for the anti-
proliferative conduct of PP extract. Here we have also shown the inhibitory impact of PP extract on 
HTB140 melanoma cell line, although these cells responded to PP extract in lesser extend compared 
to other tested cell lines. Moreover, decreased viability of HTB177 lung cancer cells was also found 
after administration of PP extract. According to the published data, cytotoxic effect of PP extract was 
as well confirmed in human lung adenocarcinoma A549 cells [43]. Taking into account IC50 values 
and selectivity index determined in present study, MCF7 breast adenocarcinoma cells are the most 
sensitive, among tested cell lines, to the treatment with PP extract. High responsiveness of MCF7 
cells to PP extract was previously reported in literature [43]. Moreover, it has been shown that PP 
extract reduces proliferation and induces apoptosis in MCF-7 cells depending on concentration 
applied and incubation time [44]. 
Considering the results assessed by clonogenic assay, MCF-7 and HCT166 cells were 
estimated as sensitive to selected doses of PP extract, contrary to HTB140 cells which were more 
resistant to the treatment (Figure 3). According to the results of Kasimsetty and colleagues [45], 
ellagitannins and urolithins from pomegranate juice decreases clonogenic efficiency of HT-29 colon 
cancer cells. They also demonstrated that these components induced cell cycle arrest in the G0/G1 
and G2/M stages of the cell cycle and suggested that ellagitannins and urolithins from pomegranate 
juice could potentially limit the risk of colon cancer [45]. Survival data from the present study 
showed that the most resistant to PP extract were HTB177 cells with SF(16 µg/mL) value of 0.74. 
Also, HTB140 cells having SF(16 µg/mL) of 0.47 and SI˂2 are considered to be resistant to the 
treatment. The most sensitive cell lines were MCF7 and HCT116 (Figure 3). These results are in 
accordance with the cytotoxicity data (Figure 1 and Table 3). Namely, as demonstrated by the 
increase in IC50 values, HTB177 and HTB140 cells showed slight recovery at the end of 48 hours 
compared to 24 hours. This is reflected in the higher survival rate compared to other cancer cell 
lines. Moreover, the MCF7 and HCT116 cells, which showed an increase in cell death at the end of 
48 hours in the cytotoxicity assay, have also been inhibited by the extract in the clonogenic assay 
(Table 3, Figure 3). Major changes in cell cycle distribution upon the administration of PP extract 
were not detected. Namely, as presented in Figure 4, only HTB140 melanoma cells demonstrated 
changes in cell cycle distribution after the treatment with PP extract at 48 h, with the increase of cells 
in G2/M phase and the reduction in S phase compared to the untreated control. Literature data 
Keta et.al., Rec. Nat. Prod. (2020) 14:5 326-339 
 
337 
obtained for wound healing assay showed that PP extract has the potential to inhibit migration of 
prostate cancer cells which represents one of the critical steps of metastasis [46]. In the present study, 
PP extract exhibited the highest inhibitory potential against migration of the HTB177 cells compared 




In the present study it is shown that aqueous-ethanol pomegranate peel extract (PP) is a 
potential anticancer agent with high selective for malignant cells compared to normal cell line. With 
the selectivity criteria of SI>2 estimated at 48 h, three cancer cell lines were considered to be 
sensitive to the PP extract. With an exception of HTB140 cells, the degree of sensitivity to PP extract 
varied among the tested cell lines (HTB177 < HCT116 < MCF7), with MCF7 cells being the most 
sensitive. Obtained differences in biological responses among tested cell lines estimated through 
changes in clonogenic survival, cell cycle and migration after the administration of PP extract may 
be due to different nature of the cells. However, since oxidant properties of polyphenols may be both 
anti-oxidant and/or pro-oxidant based upon the cellular redox context, the exact mechanisms 
underlying biological responses of these cells to the PP extract still need to be addressed. The results 
reveal that PP extract exhibits good inhibitory effects on tested cancer cell lines and would be 
exploited in future experiments including combined treatments with other anti-cancer remedy, in 
particular radiation therapy. 
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